G protein-mediated effects on cAMP production were evaluated in the corpus striatum of diabetic rats 5 and 14 weeks after alloxan injection by measuring both D1-receptor-induced stimulation and D2-receptor-mediated inhibition of adenylate-cyclase activity. At 5 weeks of diabetes, no obvious alterations of G protein functions were detected. Both dopamine-stimulated adenylate cyclase and bromocriptine-induced inhibition of enzyme activity were indeed similar in control and diabetic animals. Fourteen weeks after alloxan injection, profound alterations were observed. Dopamine-stimulated cAMP production was markedly increased in diabetic rats, whereas bromocriptine ability to reduce cAMP formation was almost abolished at this late stage of diabetes. Hypoactivity of G(i)/G(o) proteins was also confirmed by the reduced ability of the GTP non-hydrolyzable analog GTP-γ-S to inhibit forskolin-stimulation of adenylate cyclase. These results show an apparent functional imbalance between G(s) and G(i)/G(o)-mediated transduction mechanisms, with an increased efficacy of G(s) activity likely due to the loss of G(i)/G(o) inhibitory functions. Concomitantly with such transductional alteration detected in chronic diabetes, we observed a marked increase of the striatal content of met-enkephalin, which is known to utilize G(i)/G(o) proteins for inhibition of adenylate cyclase. The measurement of other transmitters (vaso-active intestinal peptide, substance P, serotonin, noradrenaline, and dopamine) did not reveal any difference with respect to controls. The observed transductional defect in diabetic animals and the increased content and/or hyperinnervation by the met-enkephalinergic system could be correlated as mutual compensatory mechanisms.

Denervation and hyperinnervation in the nervous system of diabetic animals: III. Functional alterations of G proteins in diabetic encephalopathy / M.P. Abbracchio, M.M.G. Di Luca, A.M. Di Giulio, F. Cattabeni, B. Tenconi, A. Gorio. - In: JOURNAL OF NEUROSCIENCE RESEARCH. - ISSN 0360-4012. - 24:4(1989), pp. 517-523.

Denervation and hyperinnervation in the nervous system of diabetic animals: III. Functional alterations of G proteins in diabetic encephalopathy

M.P. Abbracchio
;
M.M.G. Di Luca;A.M. Di Giulio;A. Gorio
Ultimo
1989

Abstract

G protein-mediated effects on cAMP production were evaluated in the corpus striatum of diabetic rats 5 and 14 weeks after alloxan injection by measuring both D1-receptor-induced stimulation and D2-receptor-mediated inhibition of adenylate-cyclase activity. At 5 weeks of diabetes, no obvious alterations of G protein functions were detected. Both dopamine-stimulated adenylate cyclase and bromocriptine-induced inhibition of enzyme activity were indeed similar in control and diabetic animals. Fourteen weeks after alloxan injection, profound alterations were observed. Dopamine-stimulated cAMP production was markedly increased in diabetic rats, whereas bromocriptine ability to reduce cAMP formation was almost abolished at this late stage of diabetes. Hypoactivity of G(i)/G(o) proteins was also confirmed by the reduced ability of the GTP non-hydrolyzable analog GTP-γ-S to inhibit forskolin-stimulation of adenylate cyclase. These results show an apparent functional imbalance between G(s) and G(i)/G(o)-mediated transduction mechanisms, with an increased efficacy of G(s) activity likely due to the loss of G(i)/G(o) inhibitory functions. Concomitantly with such transductional alteration detected in chronic diabetes, we observed a marked increase of the striatal content of met-enkephalin, which is known to utilize G(i)/G(o) proteins for inhibition of adenylate cyclase. The measurement of other transmitters (vaso-active intestinal peptide, substance P, serotonin, noradrenaline, and dopamine) did not reveal any difference with respect to controls. The observed transductional defect in diabetic animals and the increased content and/or hyperinnervation by the met-enkephalinergic system could be correlated as mutual compensatory mechanisms.
Corpus striatum; Diabetic encephalopathy; Dopamine; Met-enkephalin; Synaptic transduction
Settore BIO/14 - Farmacologia
1989
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/184678
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 31
social impact